Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Marcellusi

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Will the COVID-19 pandemic affect HCV disease burden?Loreta A Kondili, Andrea Marcellusi, Stephen Ryder, et al.
Recenti Progressi in Medicina|October 8, 2015
[Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study]Andrea Marcellusi, Raffaella Viti, Cristoforo Incorvaia, et al.
Clinical Drug Investigation|January 12, 2017
Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive PatientsFrancesco Saverio Mennini, Andrea Marcellusi, Lara Gitto, et al.
Global & Regional Health Technology Assessment|September 16, 2024
Chiara Bini, Andrea Marcellusi, Paolo Di Rienzo, et al.
Global & Regional Health Technology Assessment|May 7, 2025
Andrea Marcellusi, Chiara Bini, Laura Fioravanti, et al.
Clinical Drug Investigation|August 26, 2018
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic MelanomaFrancesco S Mennini, Chiara Bini, Andrea Marcellusi, et al.
Clinical Drug Investigation|September 18, 2025
Cost-Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small-Cell Lung Cancer in ItalyAndrea Marcellusi, Marco Belfiore, Rosaria Tempre, et al.
Global & Regional Health Technology Assessment|March 16, 2026
The societal costs associated with patients with chronic spontaneous urticaria (CSU) in ItalyChiara Bini, Andrea Marcellusi, Virginia Scansetti, et al.
Applied Health Economics and Health Policy|October 12, 2021
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling AnalysisAndrea Marcellusi, Claudia Simonelli, Francesco S Mennini, et al.
Health Economics Review|September 30, 2025
The economic benefit of implementing assisted reproductive technology within a national health system: insights from the Italian modelAndrea Marcellusi, Matteo Scortichini, Giulio Guarnotta, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2020
Will the COVID-19 pandemic affect HCV disease burden?Loreta A Kondili, Andrea Marcellusi, Stephen Ryder, et al.
Recenti Progressi in Medicina|October 8, 2015
[Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study]Andrea Marcellusi, Raffaella Viti, Cristoforo Incorvaia, et al.
Clinical Drug Investigation|January 12, 2017
Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive PatientsFrancesco Saverio Mennini, Andrea Marcellusi, Lara Gitto, et al.
Global & Regional Health Technology Assessment|September 16, 2024
Chiara Bini, Andrea Marcellusi, Paolo Di Rienzo, et al.
Global & Regional Health Technology Assessment|May 7, 2025
Andrea Marcellusi, Chiara Bini, Laura Fioravanti, et al.
Clinical Drug Investigation|August 26, 2018
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic MelanomaFrancesco S Mennini, Chiara Bini, Andrea Marcellusi, et al.
Clinical Drug Investigation|September 18, 2025
Cost-Estimation Model of Prevented Recurrences with Atezolizumab in Early Non-Small-Cell Lung Cancer in ItalyAndrea Marcellusi, Marco Belfiore, Rosaria Tempre, et al.
Global & Regional Health Technology Assessment|March 16, 2026
The societal costs associated with patients with chronic spontaneous urticaria (CSU) in ItalyChiara Bini, Andrea Marcellusi, Virginia Scansetti, et al.
Applied Health Economics and Health Policy|October 12, 2021
Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling AnalysisAndrea Marcellusi, Claudia Simonelli, Francesco S Mennini, et al.
Health Economics Review|September 30, 2025
The economic benefit of implementing assisted reproductive technology within a national health system: insights from the Italian modelAndrea Marcellusi, Matteo Scortichini, Giulio Guarnotta, et al.
Pageof 11